ArticleOphthalmology and therapy2024

XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration.

Jean-François Korobelnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.